ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the launch of its new medical cannabis brand, Beacon Medical. The company developed the brand based on a deep consumer understanding that it obtained through an exclusive study of 1,500 Canadians. The study showed that consumers needed a brand that makes the process of obtaining and using medical cannabis easier to navigate. Beacon Medical intends to help patients and their healthcare provider find the best treatment option amid the complex medical cannabis market by providing excellent customer service, simple registration and product classification, efficient purchasing and pharmaceutical-grade products. The full Beacon Medical website and product line, including cannabis oils, is anticipated to be available to ACMPR patients by early summer 2018. Additionally, investors will be able to get a first look at Beacon Medical at the Lift Expo taking place in Toronto from May 25t to 27th, 2018. “Our vision is to leverage our unique experience in the global pharmaceutical industry to create one of the most respected medical cannabis companies. The launch of Beacon is an important step towards that vision,” ABcann Global CEO Barry Fishman stated in the news release.
ABcann is recognized for high-quality, trusted products and services. It holds production and sales licenses from Health Canada, and its flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centered on its specially designed, environmentally-controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products. ABcann is expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, such as Germany, Australia and Israel. For more information, visit www.ABcannGlobal.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
